Back
Tandem Diabetes Care Stock Price Chart

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
71
TNDM
Tandem Diabetes Care
Last Price:
$23.06
Seasonality Move:
19.46%
7 Day Trial
ALL ACCESS PASS
$
7

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TNDM is experiencing slight buying pressure.
Tandem Diabetes Care Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.68 | Buy |
20-day SMA: | 19.86 | Buy |
50-day SMA: | 19.12 | Buy |
200-day SMA: | 32.1 | Sell |
8-day EMA: | 22.34 | Buy |
20-day EMA: | 20.85 | Buy |
50-day EMA: | 21.43 | Buy |
200-day EMA: | 28.98 | Sell |
Tandem Diabetes Care Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.13 | Buy |
Relative Strength Index (14 RSI): | 65.06 | Buy |
Chaikin Money Flow: | 222309 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.68 - 21.98) | Buy |
Bollinger Bands (100): | (18.41 - 34.95) | Sell |
Tandem Diabetes Care Technical Analysis
May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Tandem Diabetes Care Stock
Is Tandem Diabetes Care Stock a Buy?
-
Tandem Diabetes Care share price is 22.70 while TNDM 8-day simple moving average is 22.68, which is a Buy signal.
-
The stock price of TNDM is 22.70 while Tandem Diabetes Care 20-day SMA is 19.86, which makes it a Buy.
-
Tandem Diabetes Care 50-day simple moving average is 19.12 while TNDM share price is 22.70, making it a Buy technically.
-
TNDM stock price is 22.70 and Tandem Diabetes Care 200-day simple moving average is 32.10, creating a Sell signal.
TNDM Technical Analysis vs Fundamental Analysis
Buy
71
Tandem Diabetes Care (TNDM)
is a Buy
Is Tandem Diabetes Care a Buy or a Sell?
-
Tandem Diabetes Care stock is rated a BuyThe current Tandem Diabetes Care [TNDM] share price is $22.70. The Score for TNDM is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
Tandem Diabetes Care Stock Info
Market Cap:
1.5B
Price in USD:
22.70
Share Volume:
1.1M
Tandem Diabetes Care 52-Week Range
52-Week High:
53.69
52-Week Low:
15.75
Buy
71
Tandem Diabetes Care (TNDM)
is a Buy
Tandem Diabetes Care Share Price Forecast
-
What is the Tandem Diabetes Care stock price today?The Tandem Diabetes Care stock price is 22.70 USD today.
-
Will TNDM stock go up or go down?Tandem Diabetes Care> share price is forecast to RISE/FALL based on technical indicators
-
Is Tandem Diabetes Care overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Tandem Diabetes Care is not overvalued.
Is Tandem Diabetes Care Stock a Buy?
-
Tandem Diabetes Care share price is 22.70 while TNDM 8-day exponential moving average is 22.34, which is a Buy signal.
-
The stock price of TNDM is 22.70 while Tandem Diabetes Care 20-day EMA is 20.85, which makes it a Buy.
-
Tandem Diabetes Care 50-day exponential moving average is 21.43 while TNDM share price is 22.70, making it a Buy technically.
-
TNDM stock price is 22.70 and Tandem Diabetes Care 200-day simple moving average is 28.98, creating a Sell signal.
Fundamental Analysis of Tandem Diabetes Care
Is Tandem Diabetes Care a good investment?
-
Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.02 per share, an increase this year of $0.18 per share, and an increase next year of $0.83 per share.
Technical Analysis of Tandem Diabetes Care
Should I short Tandem Diabetes Care stock?
-
TNDM Moving Average Covergence Divergence (MACD) indicator is 1.13, suggesting Tandem Diabetes Care is a Buy
-
Tandem Diabetes Care Relative Strength Index (RSI) is 65.06, which suggest Tandem Diabetes Care is overbought
-
The Bollinger Bands (25) for Tandem Diabetes Care is (16.68 - 21.98), which suggest Tandem Diabetes Care is a Sell
-
The Bollinger Bands (100) for Tandem Diabetes Care is (18.41 - 34.95), which suggest Tandem Diabetes Care is a Sell
* Tandem Diabetes Care stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.